A modified PCR-RFLP genotyping method demonstrates the presence of the HPA-4b platelet alloantigen in a North American Indian population

[1]Friedman JM, Aster RH. Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a “new” maternal antiplatelet antibody. Blood 1985;65: 1412–5.10.1182/blood.V65.6.1412.bloodjournal6561412Search in Google Scholar

[2]Shibata Y, Matsuda I, Miyaji T, Ichikawa Y. Yuk^a, a new platelet antigen involved in two cases of neonatal alloimmune thrombocytopenia. Vox Sang 1986;50:177–80.10.1111/j.1423-0410.1986.tb04874.xSearch in Google Scholar

[3]Shibata Y, Miyaji T, Ichikawa Y, Matsuda I. A new platelet antigen system, Yuk^a/Yuk^b. Vox Sang 1986;51:334–6.10.1111/j.1423-0410.1986.tb01980.xSearch in Google Scholar

[4]Furihata K, Nugent DJ, Bissonette A, Aster RH, Kunicki TJ. On the association of the platelet-specific alloantigen, Pen^a, with glycoprotein IIIa: evidence for heterogeneity of glycoprotein IIIa. J Clin Invest 1987;80:1624–30.10.1172/JCI113250Search in Google Scholar

[5]Wang L, Juji T, Shibata Y, Kuwata S, Tokunaga K. Sequence variation of human platelet membrane glycoprotein IIIa associated with the Yuk^a/Yuk^b alloantigen system. Proc Japan Acad 1991;67 (B):102–6.10.2183/pjab.67.102Search in Google Scholar

[6]Wang R, Furihata K, McFarland JG, Friedman K, Aster RH, Newman PJ. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pen^a/Pen^b alloantigen system. J Clin Invest 1992;90:2038–43.10.1172/JCI116084Search in Google Scholar

[7]Matsuda T, Yonaha H, Azuma E, Sakurai M, Imai S. Neonatal alloimmune thrombocytopenic purpura associated with sensitization against the plateletspecific antigen Yuk^a. Am J Hematol 1990;35: 199–202.10.1002/ajh.2830350311Search in Google Scholar

[8]Matsui K, Ohsaki E, Goto A, Koresawa M, Kigasawa H, Shibata Y. Perinatal intracranial hemorrhage due to severe neonatal alloimmune thrombocytopenic purpura (NAITP) associated with anti-Yuk^b (HPA-4a) antibodies. Brain & Development 1995;17:352–5.10.1016/0387-7604(95)00071-ISearch in Google Scholar

[9]Kiefel V, Santoso S, Katzmann B, Mueller-Eckhardt C. A new platelet-specific alloantigen Br^a. Vox Sang 1988;54:101–6.10.1111/j.1423-0410.1988.tb01625.x3376460Search in Google Scholar

[10]Kim HO, Jin Y, Kickler TS, Blakemore K, Kwon OH, Bray PF. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion 1995;35:863–7.10.1046/j.1537-2995.1995.351096026369.x7570918Search in Google Scholar

[11]Morel-Kopp M-C, Blanchard B, Kiefel V, Joly C, Mueller-Eckhardt C, Kaplan C. Anti-HPA–4b (anti- Yuk^a) neonatal alloimmune thrombocytopenia: first report in a Caucasian family. Transfus Med 1992;2:273–6.10.1111/j.1365-3148.1992.tb00169.xSearch in Google Scholar

[12]Simon TL, Collins J, Kunicki TJ, Furihata K, Smith KJ, Aster RH. Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pen^a. Am J Hematol 1988;29:38–40.10.1002/ajh.2830290109Search in Google Scholar

[13]Zimrin AB, Gidwitz S, Lord S, et al. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990;265:8590–5.10.1016/S0021-9258(19)38928-8Search in Google Scholar

[14]Skogen B, Bellissimo DB, Hessner MJ, et al. Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion 1994;34:955–60.10.1046/j.1537-2995.1994.341195065032.xSearch in Google Scholar

[15]Haliassos A, Chomel JC, Tesson L, et al. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 1989;17:3606.10.1093/nar/17.9.3606Search in Google Scholar

[16]Reiner AP, Thompson AR. Screening for nonsense mutations in patients with severe hemophilia A can provide rapid, direct carrier detection. Hum Genet 1992;89:88–94.10.1007/BF00207049Search in Google Scholar

[17]Rabès JP, Trossaert M, Conard J, Samama M, Giraudet P, Boileau C. Single point mutation at Arg⁵⁰⁶ of factor V associated with APC resistance and venous thromboembolism: improved detection by PCR-mediated site-directed mutagenesis. Thromb Haemost 1995;74:1379–80.10.1055/s-0038-1649943Search in Google Scholar

[18]Loda M. Polymerase chain reaction-based methods for the detection of mutations in oncogenes and tumor suppressor genes. Hum Pathol 1994;25: 564–71.10.1016/0046-8177(94)90220-8Search in Google Scholar

[19]Chang JG, Chiou SS, Perng LI, et al. Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites: five mutations account for most G6PD deficiency cases in Taiwan. Blood 1992;80:1079–82.10.1182/blood.V80.4.1079.1079Search in Google Scholar

[20]Gasparini P, Bonizzato A, Dognini M, Pignatti PF. Restriction site generating–polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations. Mol Cell Probes 1992;6:1–7.10.1016/0890-8508(92)90064-5Search in Google Scholar

[21]Kwok S, Kellogg DE, McKinney N, et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res 1990;18: 999–1005.10.1093/nar/18.4.999Search in Google Scholar

[22]Metcalfe P, Waters AH. HPA-1 typing by PCR amplification with sequence-specific primers (PCR-SSP): a rapid and simple technique. Br J Haematol 1993;85:227–9.10.1111/j.1365-2141.1993.tb08680.xSearch in Google Scholar

[23]Tanaka S, Taniue A, Nagao N, et al. Simultaneous DNA typing of human platelet antigens 2, 3 and 4 by an allele-specific PCR method. Vox Sang 1995;68:225–30.10.1111/j.1423-0410.1995.tb02577.xSearch in Google Scholar

[24]Ugozzoli L, Wallace RB. Allele-specific polymerase chain reaction. Methods: a companion to methods in enzymology 1991;2:42–8.10.1016/S1046-2023(05)80124-0Search in Google Scholar

[25]McFarland JG, Aster RH, Bussel JB, Gianopoulos JG, Derbes RS, Newman PJ. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood 1991;78:2276–82.10.1182/blood.V78.9.2276.2276Search in Google Scholar

[26]Fujiwara K, Tokunaga K, Isa K, et al. DNA-based typing of human platelet antigen systems by polymerase chain reaction–single-stranded conformation polymorphism method. Vox Sang 1995;69: 347–51.Search in Google Scholar

[27]Peyruchaud O, Nurden A, Bourre F. Non-radioactive SSCP for genotyping human platelet alloantigens. Br J Haematol 1995;89:633–6.10.1111/j.1365-2141.1995.tb08376.x7734366Search in Google Scholar

[28]Bray PF, Jin Y, Kickler T. Rapid genotyping of the five major platelet alloantigens by reverse dot-blot hybridization. Blood 1994;84:4361–7.10.1182/blood.V84.12.4361.bloodjournal84124361Search in Google Scholar

[29]Legler TJ, Köhler M, Mayr WR, Panzer S, Ohto H, Fischer GF. Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing. Transfusion 1996;36:426–31.10.1046/j.1537-2995.1996.36596282586.x8693507Search in Google Scholar

[30]Simsek S, Faber NM, Bleeker PM, et al. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood 1993;81:835–40.10.1182/blood.V81.3.835.bloodjournal813835Search in Google Scholar

[31]Unkelbach K, Kalb R, Santoso S, Kroll H, Mueller- Eckhardt C, Kiefel V. Genomic RFLP typing of human platelet alloantigens Zw(P1^A), Ko, Bak and Br (HPA-1, 2, 3, 5). Br J Haematol 1995;89:169–76.10.1111/j.1365-2141.1995.tb08925.x7833258Search in Google Scholar

[32]Tanaka S, Taniue A, Nagao N, et al. Genotype frequencies of the human platelet antigen, Ca/Tu, in Japanese, determined by a PCR-RFLP method. Vox Sang 1996;70:40–4.10.1111/j.1423-0410.1996.tb00995.x8928490Search in Google Scholar

[33]Matsuo K, Reid DM. Allele-specific restriction analysis of human platelet antigen system 4. Transfusion 1996;36:809–12.10.1046/j.1537-2995.1996.36996420759.x8823456Search in Google Scholar

[34]Han KS, Cho HI, Kim SI. Frequency of platelet-specific antigens among Koreans determined by a simplified immunofluorescence test. Transfusion 1989;29:708–10.10.1046/j.1537-2995.1989.29890020445.x2678628Search in Google Scholar

[35]Urwijitaroon Y, Barusrux S, Romphruk A, Puapairoj C. Frequency of human platelet antigens among blood donors in northeastern Thailand. Transfusion 1995;35:868–70.10.1046/j.1537-2995.1995.351096026370.x7570919Search in Google Scholar

[36]Santoso S, Santoso S, Kiefel V, Masri R, Mueller- Eckhardt C. Frequency of platelet-specific antigens among Indonesians. Transfusion 1993;33:739–41.10.1046/j.1537-2995.1993.33994025024.x8212121Search in Google Scholar

[37]Inostroza J, Kiefel V, Mueller-Eckhardt C. Frequency of platelet-specific antigens P1^A1, Bak^a, Yuk^a, and Br^a in South American (Mapuches) Indians. Transfusion 1988;28:586–7.10.1046/j.1537-2995.1988.28689059037.x2461608Search in Google Scholar

[38]Fagan BF. The great journey: the peopling of the ancient Americans. London: Thames and Hudson, 1987.Search in Google Scholar